期刊文献+

MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer 被引量:2

MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer
暂未订购
导出
摘要 Objective: To explore the association of membrane-associated guanylate kinase inverted 1(MAGI1) with gastric cancer(GC) and the related molecular mechanisms.Methods: The reverse transcription-polymerase chain reaction(RT-PCR) and immunohistochemistry(IHC)were utilized to measure the MAGI1 expression level in GC tissues. Quantitative real-time PCR and Western blotting were used to ensure the MAGI1 expression in GC cell lines. Small hairpin RNA(sh RNA) was applied for knockdown of endogenous MAGI1 in GC cells. MTT assay and colony formation assay, scratch wounding migration assay and transwell chamber migration assay, as well as transwell chamber invasion assay were employed respectively to investigate the GC cell proliferation, migration and invasion in MAGI1-knockdown and control GC cells. The potential molecular mechanism mediated by MAGI1 was studied using Western blotting and RT- PCR.Results: RT-PCR and IHC verified MAGI1 was frequently expressed in matched adjacent noncancerous mucosa compared with GC tissues and the expression of MAGI1 was related to clinical pathological parameters. Functional assays indicated that MAGI1 knockdown significantly promoted GC cell migration and invasion. Further mechanism investigation demonstrated that one pathway of MAGI1 inhibiting migration and invasion was mainly by altering the expression of matrix metalloproteinases(MMPs) and epithelial-mesenchymal transition(EMT)-related molecules via inhibiting MAPK/ERK signaling pathway.Conclusions: MAGI1 was associated with GC clinical pathological parameters and acted as a tumor suppressor via inhibiting of MAPK/ERK signaling pathway in GC. Objective: To explore the association of membrane-associated guanylate kinase inverted 1(MAGI1) with gastric cancer(GC) and the related molecular mechanisms.Methods: The reverse transcription-polymerase chain reaction(RT-PCR) and immunohistochemistry(IHC)were utilized to measure the MAGI1 expression level in GC tissues. Quantitative real-time PCR and Western blotting were used to ensure the MAGI1 expression in GC cell lines. Small hairpin RNA(sh RNA) was applied for knockdown of endogenous MAGI1 in GC cells. MTT assay and colony formation assay, scratch wounding migration assay and transwell chamber migration assay, as well as transwell chamber invasion assay were employed respectively to investigate the GC cell proliferation, migration and invasion in MAGI1-knockdown and control GC cells. The potential molecular mechanism mediated by MAGI1 was studied using Western blotting and RT- PCR.Results: RT-PCR and IHC verified MAGI1 was frequently expressed in matched adjacent noncancerous mucosa compared with GC tissues and the expression of MAGI1 was related to clinical pathological parameters. Functional assays indicated that MAGI1 knockdown significantly promoted GC cell migration and invasion. Further mechanism investigation demonstrated that one pathway of MAGI1 inhibiting migration and invasion was mainly by altering the expression of matrix metalloproteinases(MMPs) and epithelial-mesenchymal transition(EMT)-related molecules via inhibiting MAPK/ERK signaling pathway.Conclusions: MAGI1 was associated with GC clinical pathological parameters and acted as a tumor suppressor via inhibiting of MAPK/ERK signaling pathway in GC.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2017年第1期25-35,共11页 中国癌症研究(英文版)
基金 supported by the Young Talents of Science and Technology Support Project of Colleges and Universities of Inner Mongolia Autonomous Region (NJYT-12-B21, 2012) the Great Project of the Affiliated Hospital of Inner Mongolia Medical University (No. NYFY ZD 2012014) the National Natural Science Foundation of China (No. 81260363) Beijing Municipal Administration of Hospitals’ Youth Programme (No. QML20151003) the Project supported by National Science and Technology Ministry (No. 2014BAI09B02) Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (No. ZYLX201701)
关键词 MAGI1 migration INVASION MAPK/ERK MMPS EMT gastric cancer MAGI1 migration invasion MAPK/ERK MMPs EMT gastric cancer
  • 相关文献

参考文献4

二级参考文献69

  • 1Kobayashi O, Sugiyama Y, Cho H, et al. Clinical and pathologicalstudy of gastric cancer with ovarian metastasis [J]. Int J Clin Oncol,2003,8(2):67-71.
  • 2Kim NK, Kim HK, Park et al. Risk factors for ovarian metasta-sis following curative resection of gastric adenocarcinoma[J]. Can-cer, 1999, 85(7):1490-1499.
  • 3WangJ, Shi YK, Wu LY, et al. Prognostic factors for ovarian metas-tases from primary gastric cancer[J]. IntJ Gynecol Cancer, 2008, 18(4):825-832.
  • 4Yada—Hashimoto N, Yamamoto T, Kamiura SS, et al. Metastaticovarian tumors: a review of 64 cases[J]. Gynecol Oncol, 2003, 89(2):314—317.
  • 5Al—Agha OM, Nicastri AD. An in—depth look at Krukenberg tumor:an overview[J]. Arch Pathol Lab Med, 2006, 130(11):1725-1730.
  • 6Yamanishi Y, Koshiyama M, Ohnaka M, et al. Pathways of metas-tases from primary organs to the ovaries [J]. Obstet Gynecol Int,2011,612817.
  • 7Yook JH, Oh ST, Kim BS. Clinical prognostic factors for ovarianmetastasis in women with gastric cancer [J], Hepatogastroenterolo-gy, 2007,54(75):955-959.
  • 8Sodek KL, Murphy iy, Brown TJ, et al. Cell—cell and cell—matrixdynamics in intraperitoneal cancer metastasis[J]. Cancer MetastasisRev, 2012, 31(1-2):397-414.
  • 9Kobayashi O, Sugiyama Y, Cho H, et al. Clinical and pathologicalstudy of gastric cancer with ovarian metastasis [J]. IntJ Clin Oncol,2003,8(2):67-71.
  • 10Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors:spectrum of CT and MR features with pathologic correlation[J]. Ab-dom Imaging, 2007, 32(6):784-795.

共引文献381

同被引文献4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部